The patent relates to a pharmaceutical composition (edoxaban) useful as an anticoagulant, which comprises a component that is improved in dissolution property.
Brief outline of the case
The patent was maintained by the OD according to a MR.
Both opponents appealed the decision.
The board considered that claim 1 as maintained was novel and inventive,